Morning Overview on MSN

Single DMT dose delivers long-lasting relief from depression

A single intravenous dose of dimethyltryptamine, the psychoactive compound found in the Amazonian brew ayahuasca, produced significant and lasting reductions in depression symptoms across a ...

What causes depression? What we know, don’t know and suspect

The idea that depression is caused by a chemical imbalance in the brain is more than half a century old. The reality is more ...
MPR

Synthetic Psilocybin Improves Symptom Severity in Treatment-Resistant Depression

Updated Part B results demonstrated sustained efficacy for COMP360 psilocybin 25mg, maintaining symptom severity reductions through week 26 after just 1 or 2 doses.
Business Insider

COMPASS Pathways Granted Patent Covering Use of Its Psilocybin Formulation in Addressing Treatment-resistant Depression

LONDON, Jan. 13, 2020 /CNW/ -- COMPASS Pathways, a mental health care company, announced today that it has been granted US Patent No 10,519,175, relating to methods of treating drug-resistant ...
Business Wire

Beckley Psytech Launches Phase IIa Study of Lead Candidate BPL-003, a Novel Benzoate Formulation of 5-MeO-DMT, for Treatment Resistant Depression

Dosages for the Phase IIa programme were selected following the successful completion of the double-blind stage of Beckley Psytech’s Phase I study earlier this year, which showed that BPL-003 was well ...
ksn.com

Head-to-head Trial of Prolonged-Release Oral Ketamine Formulation, KET01, and Intranasal SPRAVATO®, Finds Less Incidence of Dissociation or Cardiovascular Effects with Oral ...

MUNICH, Germany, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Ketabon GmbH (“Ketabon” or “the Company”), a joint venture between HMNC Brain Health and Develco Pharma, announced today favorable results from its ...

One in five will experience depression. Here’s what causes it

No single ‘depression gene’ has been found, but large studies have identified over 100 genetic risk markers on chromosomes ...